Evaluation of neonatal screening for congenital adrenal hyperplasia.
Neonatal screening for congenital hypothyroidism has been effective in early detection and treatment of the condition. The position with respect to neonatal screening for congenital adrenal hyperplasia has been debated for many years. Some countries have performed congenital adrenal hyperplasia screening for many years, others have conducted pilot studies that were then not adopted. This article endeavours to summarize the complex issues behind decisions whether to screen or not and summarizes the findings of neonatal congenital adrenal hyperplasia screening programmes.
Honour
J W
JW
Department of Chemical Pathology, University College London Hospitals, Windeyer Building, 46 Cleveland Street, London W1T 4JF, UK. john.honour@uclh.org
Torresani
T
T
D000312:Adrenal Hyperplasia, Congenital / Q000097:blood / Q000175:diagnosis* / Q000191:economics; D003362:Cost-Benefit Analysis; D005602:France; D006801:Humans; D007231:Infant, Newborn; D015997:Neonatal Screening / Q000191:economics / Q000379:methods* / Q000592:standards; D017410:Practice Guidelines as Topic / Q000592:standards; D013255:Steroid 21-Hydroxylase / Q000097:blood; D013548:Sweden
D013255:Steroid 21-Hydroxylase